About Finch Therapeutics
Finch Therapeutics is a company based in Somerville (United States) founded in 2004 by Tom Borody, Zain Kassam, and Jared James Burgess.. Finch Therapeutics has raised $184 million across 5 funding rounds from investors including Susquehanna, Octave Group and Symbiosis. The company has 1 employees as of December 31, 2024. Finch Therapeutics offers products and services including Microbiome Assets and IP Estate. Finch Therapeutics operates in a competitive market with competitors including Insitro, BridgeBio, Adaptive Biotechnologies, Moderna and ATAI, among others.
- Headquarter Somerville, United States
- Employees 1 as on 31 Dec, 2024
- Founders Tom Borody, Zain Kassam, Jared James Burgess
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Finch Therapeutics Group, Inc.
-
Annual Revenue
$0-100as on Dec 31, 2024
-
Net Profit
$-13.88 M81.44as on Dec 31, 2024
-
EBITDA
$-18.68 M42.48as on Dec 31, 2024
-
Total Equity Funding
$184 M (USD)
in 5 rounds
-
Latest Funding Round
$90 M (USD), Series D
Sep 17, 2020
-
Investors
Susquehanna
& 13 more
-
Employee Count
1
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Finch Therapeutics
Finch Therapeutics is a publicly listed company on the OTC with ticker symbol FNCH in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Finch Therapeutics
Finch Therapeutics offers a comprehensive portfolio of products and services, including Microbiome Assets and IP Estate. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portfolio for microbiome-based treatments targeting diseases
Collection of patents for microbiome innovations and applications
Unlock access to complete
Funding Insights of Finch Therapeutics
Finch Therapeutics has successfully raised a total of $184M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $90 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series D — $90.0M
-
First Round
First Round
(29 Dec 2015)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Series D - Finch Therapeutics | Valuation |
investors |
|
| Jul, 2019 | Amount | Series C - Finch Therapeutics | Valuation |
investors |
|
| Mar, 2018 | Amount | Series B - Finch Therapeutics | Valuation | Shumway Capital , Willett Advisors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Finch Therapeutics
Finch Therapeutics has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Susquehanna, Octave Group and Symbiosis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in transformative biotech companies by OMX Ventures.
|
Founded Year | Domain | Location | |
|
Diversified alternative assets are managed by the investment firm.
|
Founded Year | Domain | Location | |
|
Private equity single family office
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Finch Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Finch Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Finch Therapeutics Comparisons
Competitors of Finch Therapeutics
Finch Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, Adaptive Biotechnologies, Moderna and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Finch Therapeutics
Frequently Asked Questions about Finch Therapeutics
When was Finch Therapeutics founded?
Finch Therapeutics was founded in 2004 and raised its 1st funding round 11 years after it was founded.
Where is Finch Therapeutics located?
Finch Therapeutics is headquartered in Somerville, United States. It is registered at Somerville, Massachusetts, United States.
Is Finch Therapeutics a funded company?
Finch Therapeutics is a funded company, having raised a total of $184M across 5 funding rounds to date. The company's 1st funding round was a Series B of $36M, raised on Dec 29, 2015.
How many employees does Finch Therapeutics have?
As of Dec 31, 2024, the latest employee count at Finch Therapeutics is 1.
What does Finch Therapeutics do?
Finch Therapeutics was founded in 2004 and is based in Somerville, United States. Microbiome-based therapies are developed using a human-first discovery platform, supported by proprietary machine learning for a clinically annotated library of strains linked to clinical phenotypes. An AquaShell technology is employed for targeted delivery of microbial therapeutics. Focus is placed on Inflammatory Bowel Disease in preclinical stages, along with other applications in the biotechnology sector.
Who are the top competitors of Finch Therapeutics?
Finch Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Finch Therapeutics offer?
Finch Therapeutics offers Microbiome Assets and IP Estate.
Is Finch Therapeutics publicly traded?
Yes, Finch Therapeutics is publicly traded on OTC under the ticker symbol FNCH.
Who are Finch Therapeutics's investors?
Finch Therapeutics has 14 investors. Key investors include Susquehanna, Octave Group, Symbiosis, OMX Ventures, and MSD Partners.
What is Finch Therapeutics's ticker symbol?
The ticker symbol of Finch Therapeutics is FNCH on OTC.